Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma

Background Osteosarcoma (OS) is a rare bone tumor with a high propensity for lung metastasis and poor patient outcomes. It is crucial to identify novel therapeutic strategies and biomarkers.